Zhejiang Chimin Pharm Co Ltd Cash Flow Conversion Efficiency
Zhejiang Chimin Pharm Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Chimin Pharm Co Ltd (603222) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥3.84 Million ≈ $562.44K USD) by net assets (CN¥1.49 Billion ≈ $217.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Zhejiang Chimin Pharm Co Ltd (2011–2025)
Cash flow conversion efficiency of Zhejiang Chimin Pharm Co Ltd from 2011 to 2025. This chart illustrates how Zhejiang Chimin Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Zhejiang Chimin Pharm Co Ltd (603222) share price today for real-time trading data and today's change.
Zhejiang Chimin Pharm Co Ltd Cash Flow Conversion Ratio Explained
Zhejiang Chimin Pharm Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Zhejiang Chimin Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Chimin Pharm Co Ltd ranked by their cash flow conversion efficiency. Also see 603222 stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen TXD Technology Co Ltd
SHE:002845
|
-0.017x |
|
Chularat Hospital Public Company Limited
BK:CHG
|
0.032x |
|
San Shing Fastech Corp
TW:5007
|
0.016x |
|
Shandong Lubei Chemical Co Ltd
SHG:600727
|
0.017x |
|
Jiangsu Lianhuan Pharmaceutical Co Ltd
SHG:600513
|
-0.009x |
|
Loctek Ergonomic Technology Corp Class A
SHE:300729
|
0.095x |
|
Longjian Road & Bridge Co Ltd
SHG:600853
|
0.111x |
|
Gilat Satellite Networks Ltd
TA:GILT
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Zhejiang Chimin Pharm Co Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Chimin Pharm Co Ltd from 2011 to 2025. Review 603222 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.31 Billion ≈ $191.04 Million |
CN¥-10.35 Million ≈ $-1.51 Million |
-0.008x | -117.04% |
| 2024-12-31 | CN¥1.57 Billion ≈ $229.47 Million |
CN¥72.99 Million ≈ $10.68 Million |
0.047x | -44.90% |
| 2023-12-31 | CN¥1.66 Billion ≈ $242.89 Million |
CN¥140.20 Million ≈ $20.52 Million |
0.084x | -26.76% |
| 2022-12-31 | CN¥1.77 Billion ≈ $259.65 Million |
CN¥204.65 Million ≈ $29.95 Million |
0.115x | -45.24% |
| 2021-12-31 | CN¥1.37 Billion ≈ $201.14 Million |
CN¥289.49 Million ≈ $42.36 Million |
0.211x | +32.51% |
| 2020-12-31 | CN¥1.05 Billion ≈ $153.10 Million |
CN¥166.29 Million ≈ $24.33 Million |
0.159x | +11.61% |
| 2019-12-31 | CN¥1.07 Billion ≈ $156.99 Million |
CN¥152.77 Million ≈ $22.36 Million |
0.142x | +20.21% |
| 2018-12-31 | CN¥1.05 Billion ≈ $153.15 Million |
CN¥123.99 Million ≈ $18.14 Million |
0.118x | +65.39% |
| 2017-12-31 | CN¥928.28 Million ≈ $135.84 Million |
CN¥66.49 Million ≈ $9.73 Million |
0.072x | -19.65% |
| 2016-12-31 | CN¥808.94 Million ≈ $118.37 Million |
CN¥72.12 Million ≈ $10.55 Million |
0.089x | -23.45% |
| 2015-12-31 | CN¥750.99 Million ≈ $109.89 Million |
CN¥87.46 Million ≈ $12.80 Million |
0.116x | -33.52% |
| 2014-12-31 | CN¥441.55 Million ≈ $64.61 Million |
CN¥77.36 Million ≈ $11.32 Million |
0.175x | -20.95% |
| 2013-12-31 | CN¥488.13 Million ≈ $71.43 Million |
CN¥108.19 Million ≈ $15.83 Million |
0.222x | -43.57% |
| 2012-12-31 | CN¥432.53 Million ≈ $63.29 Million |
CN¥169.88 Million ≈ $24.86 Million |
0.393x | +357.29% |
| 2011-12-31 | CN¥383.04 Million ≈ $56.05 Million |
CN¥32.90 Million ≈ $4.81 Million |
0.086x | -- |
About Zhejiang Chimin Pharm Co Ltd
Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells in vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-pipe double-valve, single-pipe single-valve, and single-pipe double-valve soft bags; plastic bottles; and other packaging forms. It also offers injection puncture m… Read more